By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
| Currency | Euro |
| Share Price | 85.25 |
| Change Today | 0.02 |
| % Change | 0.03 % |
| 52 Week High | 109.62 |
| 52 Week Low | 77.52 |
| Volume | 220,170 |
| Shares Issued | 1,256.00m |
| Market Cap | 107,078m |
| Beta | 0.77 |
| Strong Buy | 14 |
| Buy | 8 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 27 |

| Time | Volume / Share Price |
| 12:15 | 45 @ 85.26 |
| 12:15 | 11 @ 85.25 |
| 12:15 | 74 @ 85.25 |
| 12:15 | 74 @ 85.25 |
| 12:15 | 66 @ 85.25 |
You are here: research